Enrique A. Conterno
Sr. VP, Diabetes Business Unit, Eli Lilly and Company.
Companies
- KYNTRA BIO, INC.Board member Jan 8, 2020 to Jul 10, 20231
- KYNTRA BIO, INC.Chief executive officer Jan 8, 2020 to Jul 10, 20231
- Eli Lilly and CompanySr. VP, Diabetes Business Unit Nov 10, 2009 to Feb 20, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY138,121 shares3$175.8M at $1,272.75Feb 20, 2019- KYNTRA BIO, INC. KYNB402,522 shares4$2.1M at $5.22Jul 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 7, 2023Sold 1,880 shares at $2.80 of KYNTRA BIO, INC.4
- Jun 7, 2023Sold 6,106 shares at $17.04 of KYNTRA BIO, INC.5
- Jun 7, 2023Sold 2,791 shares at $17.04 of KYNTRA BIO, INC.5
- Apr 10, 2023Sold 1,869 shares at $19.52 of KYNTRA BIO, INC.6
- Mar 10, 2023Sold 19,486 shares at $20.20 of KYNTRA BIO, INC.7
- Mar 10, 2023Sold 12,103 shares at $20.20 of KYNTRA BIO, INC.7
- Mar 10, 2023Sold 19,489 shares at $20.20 of KYNTRA BIO, INC.8
- Mar 8, 2023Granted 37,229 shares of KYNTRA BIO, INC.7
- Mar 8, 2023Granted 23,120 shares of KYNTRA BIO, INC.7
- Mar 8, 2023Sold 24,672 shares at $21.16 of KYNTRA BIO, INC.7
- Feb 21, 2023Granted 85,300 shares of KYNTRA BIO, INC.9
- Jan 6, 2023Sold 1,538 shares at $19.95 of KYNTRA BIO, INC.10
- Dec 8, 2022Sold 2,543 shares at $15.79 of KYNTRA BIO, INC.11
- Oct 6, 2022Shares withheld for tax 1,296 shares at $14.26 of KYNTRA BIO, INC.12
- Sep 6, 2022Shares withheld for tax 1,772 shares at $12.26 of KYNTRA BIO, INC.13
- Jul 6, 2022Shares withheld for tax 1,296 shares at $12.40 of KYNTRA BIO, INC.14
- Jun 6, 2022Shares withheld for tax 1,772 shares at $9.50 of KYNTRA BIO, INC.15
- Apr 7, 2022Shares withheld for tax 1,311 shares at $12.73 of KYNTRA BIO, INC.16
- Mar 7, 2022Shares withheld for tax 7,081 shares at $12.69 of KYNTRA BIO, INC.17
- Feb 14, 2022Granted 179,400 shares of KYNTRA BIO, INC.18
- Jan 6, 2022Shares withheld for tax 1,536 shares at $13.93 of KYNTRA BIO, INC.19
- Oct 6, 2021Shares withheld for tax 1,859 shares at $10.20 of KYNTRA BIO, INC.20
- Feb 15, 2019Sold 25,000 shares at $121.00 of Eli Lilly and Company3
- Feb 4, 2019Granted 26,682 shares at $120.17 of Eli Lilly and Company21
- Feb 4, 2019Granted 26,681 shares at $120.17 of Eli Lilly and Company22
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Feb 15, 2019 | LLY | Sale | $3.0M | +921.9% | −743.6% | +6.3% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARKYNTRA BIO, INC., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 9, 2023
- 6SEC EDGARForm 4 filed Apr 11, 2023
- 7SEC EDGARForm 4 filed Mar 10, 2023
- 8SEC EDGARForm 4 filed Mar 23, 2023
- 9SEC EDGARForm 4 filed Feb 23, 2023
- 10SEC EDGARForm 4 filed Jan 10, 2023
- 11SEC EDGARForm 4 filed Dec 9, 2022
- 12SEC EDGARForm 4 filed Oct 11, 2022
- 13SEC EDGARForm 4 filed Sep 8, 2022
- 14SEC EDGARForm 4 filed Jul 8, 2022
- 15SEC EDGARForm 4 filed Jun 8, 2022
- 16SEC EDGARForm 4 filed Apr 8, 2022
- 17SEC EDGARForm 4 filed Mar 9, 2022
- 18SEC EDGARForm 4 filed Feb 16, 2022
- 19SEC EDGARForm 4 filed Jan 7, 2022
- 20SEC EDGARForm 4 filed Oct 8, 2021
- 21SEC EDGARForm 4 filed Feb 20, 2019
- 22SEC EDGARForm 4 filed Feb 6, 2019